To Demonstrate the Superior Efficacy of NYC 0462 Ointment Over That of the Placebo in the Treatment of Plaque Psoriasis
NCT ID: NCT00747032
Last Updated: 2012-05-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
PHASE3
INTERVENTIONAL
2010-09-30
2011-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild to Moderate Plaque Psoriasis
NCT00746434
A Psoriasis Plaque Test Comparing Products for the Treatment of Psoriasis Vulgaris
NCT01043224
Study To Assess Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque Psoriasis
NCT04664153
A Psoriasis Plaque Test Study With LEO 90100 Cutaneous Spray, Ointment, in Psoriasis Vulgaris
NCT01347255
Evaluate Efficacy, and Safety of Topical Therapy and Etanercept in Subjects With Moderate to Severe Plaque Psoriasis
NCT01235442
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
NYC 0462 Ointment
NYC 0462 Ointment
To assess the efficacy of NYC 0462 Ointment versus Placebo in the treatment of Plaque Psoriasis
2
Placebo
Placebo
To assess the efficacy of NYC 0462 Ointment versus Placebo in the treatment of Plaque Psoriasis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NYC 0462 Ointment
To assess the efficacy of NYC 0462 Ointment versus Placebo in the treatment of Plaque Psoriasis
Placebo
To assess the efficacy of NYC 0462 Ointment versus Placebo in the treatment of Plaque Psoriasis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Good health with the exception of psoriasis
* % BSA and plaque elevation requirements
Exclusion Criteria
* Subjects who have any systemic or dermatological disorders with the exception of psoriasis
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fougera Pharmaceuticals Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nycomed US Inc.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kathleen Ocasio
Role: STUDY_CHAIR
Fougera Pharmaceuticals Inc.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NYC 0462-01-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.